| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |